ZEVRA THERAPEUTICS INC (ZVRA) Stock Balance Sheet
NASDAQ:ZVRA - Nasdaq - US4884452065 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 54.04M | 43.05M | 65.50M | 112.30M | 4.20M | |||
| Marketable Securities | 35.34M | 24.69M | 17.40M | N/A | N/A | |||
| Receivables | 7.79M | 17.38M | 8.30M | 1.50M | 2.60M | |||
| Other Current Assets | 2.28M | 1.82M | 1.90M | 1.20M | 1.60M | |||
| Total Current Assets | 99.44M | 86.94M | 93.00M | 115.10M | 8.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.43M | 1.53M | 1.80M | 2.00M | 2.40M | |||
| Investments And Advances | 6.11M | 0.00 | 20.00M | 15.40M | N/A | |||
| Goodwill | 4.70M | 4.70M | N/A | N/A | N/A | |||
| Intangibles | 70.61M | 69.23M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 9.27M | 9.94M | 700.00K | 400.00K | 400.00K | |||
| Total Non-Current Assets | 92.11M | 85.39M | 22.50M | 17.80M | 2.80M | |||
| TOTAL ASSETS | 191.55M | 172.33M | 115.50M | 132.90M | 11.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 37.70M | 4.70M | 0.00 | 600.00K | |||
| Accrued Expenses | 540.00K | 14.96M | 3.00M | 2.90M | 5.80M | |||
| Accounts Payable | 24.46M | 13.99M | 3.60M | 500.00K | 1.20M | |||
| Other Current Liabilities | 9.48M | 7.07M | 400.00K | 800.00K | N/A | |||
| Total Current Liabilities | 34.48M | 73.72M | 11.70M | 4.20M | 7.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 58.90M | 5.07M | 12.80M | 0.00 | 68.10M | |||
| Other Non-Current Liabilities | 28.40M | 31.68M | 5.20M | 1.60M | 2.00M | |||
| Total Non-Current Liabilities | 87.30M | 36.74M | 18.00M | 1.60M | 70.10M | |||
| TOTAL LIABILITIES | 121.78M | 110.46M | 29.70M | 5.80M | 77.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -469.55M | -399.78M | -308.60M | -267.00M | -258.50M | |||
| Additional Paid In Capital | 550.41M | 472.66M | 401.80M | 397.00M | 192.10M | |||
| Common Shares | 5.00K | 4.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -10.98M | -10.98M | -7.50M | -2.80M | N/A | |||
| Other Shareholders' Equity | -115.00K | -43.00K | 100.00K | N/A | 0.00 | |||
| Shares Outstanding | 53.23M | 41.53M | 34.50M | 35.00M | 4.50M | |||
| Tangible Book Value per Share | -0.10 | -0.29 | 2.49 | 3.63 | -14.76 | |||
| Total Shareholders' Equity | 69.77M | 61.86M | 85.80M | 127.10M | -66.40M | |||
| TOTAL LIABILITIES AND EQUITY | 191.55M | 172.33M | 115.50M | 132.90M | 11.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.84 | 0.08 | 0.15 | N/A | -1.03 | |||
| Current Ratio | 2.88 | 1.18 | 7.95 | 27.40 | 1.12 | |||
| Return On Assets (ROA) | -44.34% | -26.72% | -35.97% | -47.33% | -113.93% | |||
| Return On Equity (ROE) | -121.72% | -74.44% | -48.41% | -49.49% | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 4.74% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 37.24% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 37.24% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21